vTv Therapeutics Inc. (VTVT) › Capital ExpendituresvTv Therapeutics Inc. (VTVT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2013: $181.0K2014: $33.0K2015: $104.0K2016: $87.0K2017: $57.0K2018: $5.0K2019: $70.0K2020: $02021: $02022: $21.0K2023: $02024: $0$02013Capital Expenditures (USD)2024Fiscal YearCapital ExpendituresChange YoY2024$0—2023$0-100.0%2022$21.0K—2021$0—2020$0-100.0%2019$70.0K+1300.0%2018$5.0K-91.2%2017$57.0K-34.5%2016$87.0K-16.3%2015$104.0K+215.2%2014$33.0K-81.8%2013$181.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share